30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Satsuma Pharmaceuticals Inc (STSA)

Track

Stock chart
Ticker: STSA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Shin Nippon Biomedical Laboratories, Ltd.
1 purchase — total 7,665,596 USD
Buy 8 Jun 2023
Value US$2,459,558.81 | Price 112.02 | Shares 23,104
Buy 6 Jun 2023
Value US$1,131,790.07 | Price 396.63 | Shares 47,633
Buy 6 Jun 2023
Value US$20,068,758.71 | Price 0.91 | Shares 22,053,581
Buy 21 Nov 2022
Value US$106,740.00 | Price 0.71 | Shares 150,000
Buy 15 Nov 2022
Value US$188,956.11 | Price 0.63 | Shares 300,694
Buy 15 Nov 2022
Value US$336,707.10 | Price 0.63 | Shares 531,000
Buy 14 Nov 2022
Value US$3,868,609.48 | Price 0.69 | Shares 5,608,306
Sale 14 Nov 2022
Value US$2,294,500.00 | Price 0.71 | Shares 3,250,000
Buy 24 Nov 2021
Value US$15,837.24 | Price 5.42 | Shares 2,922
Buy 22 Nov 2021
Value US$54,784.71 | Price 5.49 | Shares 9,979
Buy 19 Nov 2021
Value US$17,544.00 | Price 5.44 | Shares 3,225
Buy 11 Nov 2021
Value US$48,043.05 | Price 6.05 | Shares 7,941
Buy 10 Nov 2021
Value US$56,288.70 | Price 5.85 | Shares 9,622
Buy 8 Nov 2021
Value US$3,354.40 | Price 5.99 | Shares 560
Buy 5 Nov 2021
Value US$46,410.00 | Price 5.95 | Shares 7,800
Buy 4 Nov 2021
Value US$8,232.00 | Price 5.88 | Shares 1,400
Buy 2 Nov 2021
Value US$50,083.20 | Price 5.64 | Shares 8,880
Buy 29 Oct 2021
Value US$254,957.21 | Price 5.71 | Shares 44,651
Buy 28 Oct 2021
Value US$83,705.10 | Price 5.55 | Shares 15,082
Buy 27 Oct 2021
Value US$215,716.45 | Price 5.45 | Shares 39,581
Buy 22 Oct 2021
Value US$152,235.79 | Price 5.51 | Shares 27,629
Buy 21 Oct 2021
Value US$177,206.40 | Price 5.40 | Shares 32,816
Buy 20 Oct 2021
Value US$221,206.72 | Price 5.44 | Shares 40,663
Buy 19 Oct 2021
Value US$444,030.60 | Price 5.07 | Shares 87,580
Buy 18 Oct 2021
Value US$176,264.78 | Price 4.87 | Shares 36,194
Buy 15 Oct 2021
Value US$608,580.00 | Price 4.83 | Shares 126,000
Buy 26 Feb 2021
Value US$6,999,997.92 | Price 5.68 | Shares 1,232,394
Planned sale 1 Sep 2020
Value US$22,210.00 | Price 22.21 | Shares 1,000
Planned sale 1 Sep 2020
Value US$16,644.52 | Price 22.19 | Shares 750
Planned sale 5 Aug 2020
Value US$25,000.00 | Price 25.00 | Shares 1,000
Planned sale 3 Aug 2020
Value US$4,624.02 | Price 23.12 | Shares 200
Planned sale 3 Aug 2020
Value US$18,281.60 | Price 22.85 | Shares 800
Planned sale 1 Jul 2020
Value US$2,781.00 | Price 27.81 | Shares 100
Planned sale 1 Jul 2020
Value US$16,194.72 | Price 26.99 | Shares 600
Planned sale 1 Jul 2020
Value US$7,707.33 | Price 25.69 | Shares 300
Planned sale 1 Jul 2020
Value US$8,443.64 | Price 27.59 | Shares 306
Planned sale 1 Jul 2020
Value US$10,520.08 | Price 26.70 | Shares 394
Planned sale 1 Jul 2020
Value US$7,690.20 | Price 25.63 | Shares 300
Planned sale 23 Jun 2020
Value US$74,511.87 | Price 35.23 | Shares 2,115
Planned sale 1 Jun 2020
Value US$25,256.90 | Price 25.26 | Shares 1,000
Planned sale 1 Jun 2020
Value US$25,323.50 | Price 25.32 | Shares 1,000
Planned sale 20 May 2020
Value US$50,000.00 | Price 25.00 | Shares 2,000
Planned sale 5 May 2020
Value US$20,000.00 | Price 20.00 | Shares 1,000
Planned sale 14 Apr 2020
Value US$16,000.00 | Price 20.00 | Shares 800
Planned sale 1 Apr 2020
Value US$4,049.00 | Price 20.25 | Shares 200
Planned sale 11 Mar 2020
Value US$27,422.40 | Price 27.42 | Shares 1,000
Planned sale 11 Mar 2020
Value US$27,678.00 | Price 27.68 | Shares 1,000
Buy 17 Sep 2019
Value US$1,500,000.00 | Price 15.00 | Shares 100,000
Buy 17 Sep 2019
Value US$3,499,995.00 | Price 15.00 | Shares 233,333
Buy 17 Sep 2019
Value US$2,885,805.00 | Price 15.00 | Shares 192,387
Buy 17 Sep 2019
Value US$17,114,190.00 | Price 15.00 | Shares 1,140,946
Buy 17 Sep 2019
Value US$19,999,995.00 | Price 15.00 | Shares 1,333,333
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-08 2023-06-08 B Purchase
Shin Nippon Biomedical Laboratories, Ltd.
Large shareholder
23,104 +21.3%
112.02
US$2,459,559 		23,104 +21.3% 112.02 US$2,459,559
2023-06-08 2023-06-06 B Purchase
Shin Nippon Biomedical Laboratories, Ltd.
Large shareholder
47,633 -25.0%
396.63
US$1,131,790 		47,633 -25.0% 396.63 US$1,131,790
2023-06-08 2023-06-06 B Purchase
1.4
TAKANASHI KEN
Non-Executive Director Large shareholder
37,722 -9.7%
323.18
US$3,777,084 		37,722 -9.7% 323.18 US$3,777,084
2022-11-23 2022-11-21 B Purchase
2.9
Leonard Braden Michael
Large shareholder
150,000 +inf%
0.71
US$106,740 		150,000 +inf% 0.71 US$106,740
2022-11-16 2022-11-15 B Purchase
2.9
Leonard Braden Michael
Large shareholder
300,694 +4.9%
0.63
US$188,956 		300,694 +4.9% 0.63 US$188,956
2022-11-16 2022-11-15 B Purchase
2.9
Leonard Braden Michael
Large shareholder
531,000 +9.5%
0.63
US$336,707 		531,000 +9.5% 0.63 US$336,707
2022-11-16 2022-11-14 B Purchase
2.9
Leonard Braden Michael
Large shareholder
5,608,306 +inf%
0.69
US$3,868,609 		5,608,306 +inf% 0.69 US$3,868,609
2022-11-16 2022-11-14 S Sale
1.9
COMMODORE CAPITAL LP
Large shareholder
3,250,000 -87.6%
0.71
US$2,294,500 		3,250,000 -87.6% 0.71 US$2,294,500
2021-11-29 2021-11-24 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
2,922 +0.1%
5.42
US$15,837 		2,922 +0.1% 5.42 US$15,837
2021-11-23 2021-11-22 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
9,979 +0.3%
5.49
US$54,785 		9,979 +0.3% 5.49 US$54,785
2021-11-23 2021-11-19 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
3,225 +0.1%
5.44
US$17,544 		3,225 +0.1% 5.44 US$17,544
2021-11-12 2021-11-11 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
7,941 +0.2%
6.05
US$48,043 		7,941 +0.2% 6.05 US$48,043
2021-11-12 2021-11-10 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
9,622 +0.3%
5.85
US$56,289 		9,622 +0.3% 5.85 US$56,289
2021-11-10 2021-11-08 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
560 +0.0%
5.99
US$3,354 		560 +0.0% 5.99 US$3,354
2021-11-08 2021-11-05 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
7,800 +0.2%
5.95
US$46,410 		7,800 +0.2% 5.95 US$46,410
2021-11-08 2021-11-04 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
1,400 +0.0%
5.88
US$8,232 		1,400 +0.0% 5.88 US$8,232
2021-11-04 2021-11-02 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
8,880 +0.2%
5.64
US$50,083 		8,880 +0.2% 5.64 US$50,083
2021-11-02 2021-10-29 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
44,651 +1.2%
5.71
US$254,957 		44,651 +1.2% 5.71 US$254,957
2021-10-29 2021-10-28 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
15,082 +0.4%
5.55
US$83,705 		15,082 +0.4% 5.55 US$83,705
2021-10-29 2021-10-27 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
39,581 +1.1%
5.45
US$215,716 		39,581 +1.1% 5.45 US$215,716
2021-10-25 2021-10-22 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
27,629 +0.8%
5.51
US$152,236 		27,629 +0.8% 5.51 US$152,236
2021-10-25 2021-10-21 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
32,816 +0.9%
5.40
US$177,206 		32,816 +0.9% 5.40 US$177,206
2021-10-21 2021-10-20 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
40,663 +1.2%
5.44
US$221,207 		40,663 +1.2% 5.44 US$221,207
2021-10-21 2021-10-19 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
87,580 +2.6%
5.07
US$444,031 		87,580 +2.6% 5.07 US$444,031
2021-10-19 2021-10-18 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
36,194 +1.1%
4.87
US$176,265 		36,194 +1.1% 4.87 US$176,265
2021-10-19 2021-10-15 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
126,000 +3.9%
4.83
US$608,580 		126,000 +3.9% 4.83 US$608,580
2021-03-02 2021-02-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,232,394 +31.4%
5.68
US$6,999,998 		1,232,394 +31.4% 5.68 US$6,999,998
2020-09-03 2020-09-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
22.21
US$22,210 		1,000 -4.7% 22.21 US$22,210
2020-09-03 2020-09-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
750 -100.0%
22.19
US$16,645 		750 -100.0% 22.19 US$16,645
2020-08-07 2020-08-05 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
1,000 -100.0%
25.00
US$25,000 		1,000 -100.0% 25.00 US$25,000
2020-08-05 2020-08-03 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
200 -1.0%
23.12
US$4,624 		200 -1.0% 23.12 US$4,624
2020-08-05 2020-08-03 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
800 -3.8%
22.85
US$18,282 		800 -3.8% 22.85 US$18,282
2020-07-02 2020-07-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
100 -0.5%
27.81
US$2,781 		100 -0.5% 27.81 US$2,781
2020-07-02 2020-07-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
600 -2.9%
26.99
US$16,195 		600 -2.9% 26.99 US$16,195
2020-07-02 2020-07-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
300 -1.5%
25.69
US$7,707 		300 -1.5% 25.69 US$7,707
2020-07-02 2020-07-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
306 -100.0%
27.59
US$8,444 		306 -100.0% 27.59 US$8,444
2020-07-02 2020-07-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
394 -100.0%
26.70
US$10,520 		394 -100.0% 26.70 US$10,520
2020-07-02 2020-07-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
300 -100.0%
25.63
US$7,690 		300 -100.0% 25.63 US$7,690
2020-06-24 2020-06-23 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
2,115 -100.0%
35.23
US$74,512 		2,115 -100.0% 35.23 US$74,512
2020-06-02 2020-06-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
25.26
US$25,257 		1,000 -4.7% 25.26 US$25,257
2020-06-02 2020-06-01 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
1,000 -100.0%
25.32
US$25,324 		1,000 -100.0% 25.32 US$25,324
2020-05-21 2020-05-20 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
2,000 -100.0%
25.00
US$50,000 		2,000 -100.0% 25.00 US$50,000
2020-05-06 2020-05-05 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
20.00
US$20,000 		1,000 -4.7% 20.00 US$20,000
2020-04-16 2020-04-14 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
800 -3.8%
20.00
US$16,000 		800 -3.8% 20.00 US$16,000
2020-04-03 2020-04-01 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
200 -1.0%
20.25
US$4,049 		200 -1.0% 20.25 US$4,049
2020-03-12 2020-03-11 PlS Planned sale
ALBRECHT DETLEF

Chief Medical Officer

Officer
1,000 -4.7%
27.42
US$27,422 		1,000 -4.7% 27.42 US$27,422
2020-03-12 2020-03-11 PlS Planned sale
O'Neil Thomas P.

Chief Financial Officer

Officer
1,000 -100.0%
27.68
US$27,678 		1,000 -100.0% 27.68 US$27,678
2019-09-18 2019-09-17 B Purchase
3.7
TPG Group Holdings (SBS) Advisors, Inc.
Large shareholder
100,000 +5.6%
15.00
US$1,500,000 		100,000 +5.6% 15.00 US$1,500,000
2019-09-17 2019-09-17 B Purchase
1.4
TAKANASHI KEN
233,333 +17.6%
15.00
US$3,499,995 		233,333 +17.6% 15.00 US$3,499,995
2019-09-17 2019-09-17 B Purchase
1.4
Shah Rajeev M.
Large shareholder
192,387 +4.3%
15.00
US$2,885,805 		192,387 +4.3% 15.00 US$2,885,805
2019-09-17 2019-09-17 B Purchase
1.4
Shah Rajeev M.
Large shareholder
1,140,946 +34.1%
15.00
US$17,114,190 		1,140,946 +34.1% 15.00 US$17,114,190
2019-09-17 2019-09-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, LLC
Large shareholder
1,333,333 +39.8%
15.00
US$19,999,995 		1,333,333 +39.8% 15.00 US$19,999,995
Explore more

More insider trading research around Satsuma Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America